id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-D-0464-0045,FDA,FDA-2011-D-0464,Guidances for Industry and Staff: Content of Investigational Device Exemption and Premarket Approval Applications for Artificial Pancreas Device Systems,Notice,Notice of Data Availability,2012-11-23T05:00:00Z,2012,11,2012-11-23T05:00:00Z,,2024-11-12T05:10:22Z,2012-28339,1,0,09000064811718ac
FDA-2011-D-0464-0046,FDA,FDA-2011-D-0464,The Content of Investigational Device Exemption (IDE) and Premarket Approval (PMA) Applications for Artificial Pancreas Device Systems Guidance for Industry and Food and Drug Administration Staff,Other,Guidance,2012-11-09T05:00:00Z,2012,11,2012-11-09T05:00:00Z,,2024-11-12T05:09:47Z,,1,0,09000064811726df